Submitted by elizabethwu1 on Fri, 05/11/2018 - 2:15pm NCT03446001 HMTM United States Wednesday, January 10, 2018 – Thursday, February 28, 2019 180 Phase 2/3 Alzheimer's Disease Friday, May 11, 2018 TauRx Therapeutics Ltd Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.